熱門詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
美國BioServe
BioServe公司交付完整的‘生物材料到有效數(shù)據(jù)’基因解決方案。BioServe公司能對(duì)從生物樣品中獲得的基因內(nèi)容進(jìn)行迅速的、經(jīng)濟(jì)的處理和分析,這種能力幫助世界范圍內(nèi)的研究者獲得臨床前基因結(jié)果,這些結(jié)果都是在研究、藥物發(fā)現(xiàn)以及分子診斷方面實(shí)現(xiàn)重大突破所必需的。BioServe公司的技術(shù)、產(chǎn)品和服務(wù)為實(shí)現(xiàn)最佳的臨床前工作流提供了基礎(chǔ),這些工作流涉及:處理核酸、DNA合成、大規(guī)模定序和分型、多基因定位和基因表達(dá)分析所需的革新方法。BioServe公司的客戶包括領(lǐng)先的制藥和生物技術(shù)公司、政府以及學(xué)術(shù)研究機(jī)構(gòu)。 BioServe公司總部設(shè)在馬里蘭州的Laurel和印度的Hyderabad。
Our 'biomaterial to data' model offers one of the world’s largest commercial biorepositories and a full suite of preclinical molecular services and research tools to accelerate breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics.
BioServe's Global BioRepository provides leading academic and industry researchers with access to over 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic data from 120,000 consented and anonymized patients on four continents.
Utilizing BioServe's preclinical molecular services, researchers can identify genetic markers, validate drug targets and correlate clinical and molecular data to accelerate the development of new and safer drugs.
BioServe's research tools division offers everything from from nucleic acids processing, DNA synthesis, high throughput sequencing and genotyping, genome wide-scans and gene expression analysis to ready-made large epidemiologically sound case-control studies.
BioServe's customers include nearly every major pharmaceutical and biotechnology company, as well as top industry, academic, and government research institutions.
Founded in 1989, BioServe has corporate headquarters in Beltsville, Maryland and Hyderabad, India.